MEDtuning delivers Personalized Medicine to modern clinical practices. MEDtuning develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs used to treat mental illness, pain, heart disease, and diabetes. These systems are designed to provide physicians with an unprecedented capability to select for each patient the safest and most effective drug to achieve treatment goals and enhance patient compliance.
MEDtuning, offers patients and physicians clinicians the ability to personalize drug therapy and increase safety and compliance. MEDtuning is a genetic assessment of the medicines currently prescribed or being considered for the patient, extending to 200 Neuro-Psychiatric and 160 Cardio-Metabolic drugs featured within the MEDtuning App. Deployment of this system allows the personalized management of drugs to treat mental illness, pain, diabetes, and cardiovascular disease, leading clinicians and patients to their desired treatment goal and resulting in effective and individualized healthcare.
MEDtuning has been used by more than 500 clinicians and 15,000 patients throughout the United States. Based on clinical studies and case reports, MEDtuning offers interpretative guidance to assess the individual's innate drug metabolism in order to establish and quantify functionalities and deficiencies. Clinicians and individuals are then guided to make prescribing decisions based on those metabolic capabilities and deficits. MEDtuning enables selection and adherence to the drug with the least risk and superior efficacy based on guidance from the patient's own genome.